Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ignacio López-Loureiro"'
Autor:
María Santamaría-Cadavid, Emilio Rodríguez-Castro, Manuel Rodríguez-Yáñez, Susana Arias-Rivas, Iria López-Dequidt, María Pérez-Mato, Manuel Rodríguez-Pérez, Ignacio López-Loureiro, Pablo Hervella, Francisco Campos, José Castillo, Ramón Iglesias-Rey, Tomás Sobrino
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Recent preclinical studies have shown that regulatory T cells (Treg) play a key role in the immune response after ischemic stroke (IS). However, the role of Treg in human acute IS has been poorly investigated. Our aim was to study
Externí odkaz:
https://doaj.org/article/65a04d6080974d9abc11a2afbb55631e
Autor:
Emilio Rodríguez-Castro, Manuel Rodríguez-Yáñez, Susana Arias, María Santamaría, Iria López-Dequidt, Ignacio López-Loureiro, Manuel Rodríguez-Pérez, Pablo Hervella, Tomás Sobrino, Francisco Campos, José Castillo, Ramón Iglesias-Rey
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Identifying the complexities of the effect of sex on stroke risk, etiology, and lesion progression may lead to advances in the treatment and care of ischemic stroke (IS) and non-traumatic intracerebral hemorrhage patients (ICH). We studied the sex-re
Externí odkaz:
https://doaj.org/article/5b6c144a8b69497d987ec43dccd411e2
Autor:
Tomás Sobrino, María Santamaría-Cadavid, Susana Arias-Rivas, Ramón Iglesias-Rey, José Castillo, Iria López-Dequidt, Andrés da Silva-Candal, Pablo Hervella, Emilio Rodríguez-Castro, Ignacio López-Loureiro, Manuel Rodríguez-Yáñez, Francisco Campos, María Pérez-Mato
Publikováno v:
International Journal of Cardiology. 298:93-97
Background Elevated levels of B-type natriuretic peptide (BNP) and NT-pro-BNP can predict an increased risk of cardiovascular events and ischemic stroke. The limited reliability to predict the risk of stroke after a transient ischemic attack (TIA) ju
Autor:
Emilio Rodríguez-Castro, José Castillo, Ignacio López-Loureiro, Iria López-Dequidt, Francisco Campos, Susana Arias-Rivas, Manuel Rodríguez-Pérez, Ramón Iglesias-Rey, María Santamaría-Cadavid, María Pérez-Mato, Tomás Sobrino, Pablo Hervella, Manuel Rodríguez-Yáñez
Publikováno v:
BMC Neurology
BMC Neurology, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Neurology, Vol 20, Iss 1, Pp 1-10 (2020)
BackgroundRecent preclinical studies have shown that regulatory T cells (Treg) play a key role in the immune response after ischemic stroke (IS). However, the role of Treg in human acute IS has been poorly investigated. Our aim was to study the relat
Autor:
Ramón Iglesias-Rey, José Castillo, Elena Rodríguez-Maqueda, Ignacio López-Loureiro, Clara Correa-Paz, José Manuel Pumar, Manuel Rodríguez-Yáñez, Paulo Ávila-Gómez, Tomás Sobrino, Andrés da Silva-Candal, Pablo Hervella, Francisco Campos
Publikováno v:
Neurology. 94(16)
ObjectiveTo investigate the effect on perihematomal hypodensity and outcome of a decrease in body temperature in the first 24 hours in patients with intracerebral hemorrhage (ICH).MethodsIn this retrospective study on a prospectively registered datab
Autor:
Clara Correa-Paz, Francisco Campos, Anusha Pusuluri, Ignacio López-Loureiro, Vinu Krishnan, Samir Mitragotri, Amparo Pérez-Díaz, José Castillo, Paulo Ávila-Gómez, Pablo Hervella, Tyler Brown, A. Da Silva-Candal
Publikováno v:
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
Journal of Controlled Release
instname
Journal of Controlled Release
Endothelial cells represent the first biological barrier for compounds, including nanoparticles, administered via the intravascular route. In the case of ischemic stroke and other vascular diseases, the endothelium overexpresses specific markers, whi
Autor:
Susana Cardoso, Verónica C. Martins, Ignacio López-Loureiro, Elisabete Fernandes, J. Germano, Tomás Sobrino, Francisco Campos, Dmitri Y. Petrovykh, Manuel Rodríguez-Pérez, Paulo P. Freitas, José Castillo
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine
The abundance of cellular fibronectin (c-Fn) for ischemic stroke patients and the narrow time-window (4.5 h) for the decision to administer the thrombolytic treatment with recombinant tissue plasminogen activator (rtPA) are challenging for the develo
Autor:
Francisco Campos, Tomás Sobrino, Iria López-Dequidt, Ramón Iglesias-Rey, Elena Maqueda, María Santamaría-Cadavid, Ana Estany-Gestal, Emilio Rodríguez-Castro, Susana Arias, Ignacio López-Loureiro, Pablo Hervella, José Castillo, Manuel Rodríguez-Yáñez
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Neuroprotective treatments in ischemic stroke are focused to reduce the pernicious effect of excitotoxicity, oxidative stress and inflammation. However, those cellular and molecular mechanisms may also have beneficial effects, especially during the l